"In July we announced the expansion of our collaboration with Janssen Biotech Inc and its affiliates (Janssen) to discover,develop and commercialise new classes of peptide drug conjugates derived from Phylogica’s Phylomer drug discovery platform. Phylogica is to receive undisclosed payments for funding additional research associated with this expansion."
See it's strange you can have comments like that in July 2013 and yes may be "undisclosed" in terms of promotion, but you still can't hide them from financial statements - yet receipts remain at $0 ?
The last payment and again "undisclosed" from was Janssen in January 2013 for $600K but was visible in the quarterly statement.
?
going intracellular, page-48
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
0.003(1.47%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.3¢ | 16.5¢ | $132.3K | 782.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27840 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 335096 | 9 |
View Market Depth
| Last trade - 15.07pm 08/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |